Trial Profile
Association between in vitro susceptibility to natamycin and voriconazole and clinical outcomes in fungal keratitis.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 30 Sep 2015
Price :
$35
*
At a glance
- Drugs Voriconazole (Primary) ; Natamycin
- Indications Keratitis
- Focus Therapeutic Use
- Acronyms MUTT I
- 30 Sep 2015 New trial record